Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-071432
Filing Date
2025-07-29
Accepted
2025-07-29 07:58:24
Documents
49
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K azn-20250630x6k.htm   iXBRL 6-K 4201973
7 GRAPHIC azn-20250630x6k001.jpg GRAPHIC 4829
  Complete submission text file 0001104659-25-071432.txt   12594635

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA azn-20250630.xsd EX-101.SCH 68462
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azn-20250630_cal.xml EX-101.CAL 86706
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azn-20250630_def.xml EX-101.DEF 196822
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE azn-20250630_lab.xml EX-101.LAB 442527
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azn-20250630_pre.xml EX-101.PRE 301080
52 EXTRACTED XBRL INSTANCE DOCUMENT azn-20250630x6k_htm.xml XML 2962465
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)